Correlation Between JJill and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both JJill and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JJill and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JJill Inc and Acumen Pharmaceuticals, you can compare the effects of market volatilities on JJill and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JJill with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of JJill and Acumen Pharmaceuticals.
Diversification Opportunities for JJill and Acumen Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between JJill and Acumen is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding JJill Inc and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and JJill is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JJill Inc are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of JJill i.e., JJill and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between JJill and Acumen Pharmaceuticals
Given the investment horizon of 90 days JJill Inc is expected to generate 0.47 times more return on investment than Acumen Pharmaceuticals. However, JJill Inc is 2.13 times less risky than Acumen Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 2,555 in JJill Inc on September 15, 2024 and sell it today you would earn a total of 268.00 from holding JJill Inc or generate 10.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
JJill Inc vs. Acumen Pharmaceuticals
Performance |
Timeline |
JJill Inc |
Acumen Pharmaceuticals |
JJill and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with JJill and Acumen Pharmaceuticals
The main advantage of trading using opposite JJill and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JJill position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.The idea behind JJill Inc and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Acumen Pharmaceuticals vs. Puma Biotechnology | Acumen Pharmaceuticals vs. Iovance Biotherapeutics | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |